A Study to Test for Genetic Changes that Affect Treatment in Patients With Non-Small Cell Lung Cancer
Your blood may contain certain genetic mutations that make it potentially more likely to respond to certain drugs.
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at Sacramento, California and other locations
- Dates
- study startedestimated completion
Description
Summary
Official Title
Keywords
Eligibility
Locations
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Hoffmann-La Roche
- Links
- Sign up for this study
- ID
- NCT03178552
- Phase
- Phase 2/3 research study
- Study Type
- Interventional
- Participants
- Expecting 700 study participants
- Last Updated